The compelling evidence that both exogenous mitochondrial uncouplers and UCP1 activation in BAT impair tumor growth presents a paradox when compared with the frequent upregulation of endogenous UCPs—particularly UCP2—in human cancers. This evidence concerns the gene UCP2 and cancer.